☆ 4.5 Editorial Material

The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future

HEPATOBILIARY SURGERY AND NUTRITION (2018)

Journal

HEPATOBILIARY SURGERY AND NUTRITION

Volume 7, Issue 6, Pages 487-489

Publisher

AME PUBL CO

DOI: 10.21037/hbsn.2018.10.06

Keywords

-

Categories

Gastroenterology & Hepatology Nutrition & Dietetics Surgery

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.